Polyarthritis as a complication of intravesical Bacillus Calmette-Guerin immunotherapy for bladder cancer

被引：11
|
作者：
Onur, Ö [1 ]
Çeliker, R [1 ]
机构：
[1] Hacettepe Univ Hosp, Dept Phys Med & Rehabil, Fac Med, TR-06100 Ankara, Turkey
来源：
CLINICAL RHEUMATOLOGY | 1999年 / 18卷 / 01期
关键词：
BCG immunotherapy; polyarthritis;
D O I：
10.1007/s100670050059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Bacillus Calmette-Guerin (BCG) is the most effective agent currently available for the treatment of superficial bladder cancer. However, this form of treatment is associated with some complications, including arthritis. In this report, we present a 69-year-old woman who developed inflammatory polyarthritis following BCG treatment for superficial bladder cancer. The arthritis resolved following treatment with a nonsteroidal anti-inflammatory drug and chloroquinine.
引用
收藏
页码：74 / 76
页数：3
相关论文
共 50 条
  • [1] Polyarthritis as a Complication of Intravesical Bacillus Calmette–Guerin Immunotherapy for Bladder Cancer
    Ö. Onur
    R. Çeliker
    [J]. Clinical Rheumatology, 1999, 18 : 74 - 76
  • [2] Intravesical instillation therapy with bacillus Calmette-Guerin for superficial bladder cancer: Study of the mechanism of bacillus Calmette-Guerin immunotherapy
    Shintani, Yasuyo
    Sawada, Yoshihisa
    Inagaki, Takeshi
    Kohjimoto, Yasuo
    Uekado, Yasunari
    Shinka, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (02) : 140 - 146
  • [3] Perianal abscess as a complication of intravesical administration of Bacillus Calmette-Guerin for bladder cancer
    Koksal, Aydin Seref
    Bilge, Zulfukar
    Torun, Serkan
    Sasmaz, Nurgul
    Yazicioglu, Ahmet Hamdi
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (02): : 260 - 260
  • [4] Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guerin immunotherapy
    Aust, TR
    Massey, JA
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2005, 12 (10) : 920 - 921
  • [5] Tuberculous peritonitis as a late complication of Bacillus Calmette-Guerin intravesical therapy in bladder cancer
    Halle, O
    Neau, D
    Monlun, E
    Rullier, E
    LongyBoursier, M
    LeBras, M
    [J]. REVUE DE MEDECINE INTERNE, 1996, 17 (03): : 265 - 266
  • [6] Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer
    Liu, Yuqing
    Lu, Jian
    Huang, Yi
    Ma, Lulin
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [7] BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY IN BLADDER-CANCER
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (09): : 1238 - 1240
  • [8] BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR BLADDER-CANCER
    LAMM, DL
    [J]. JOURNAL OF UROLOGY, 1985, 134 (01): : 40 - 47
  • [9] PROSPECTIVE RANDOMIZED COMPARISON OF INTRAVESICAL WITH PERCUTANEOUS BACILLUS CALMETTE-GUERIN VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN IN SUPERFICIAL BLADDER-CANCER
    LAMM, DL
    DEHAVEN, JI
    SHRIVER, J
    SAROSDY, MF
    [J]. JOURNAL OF UROLOGY, 1991, 145 (04): : 738 - 740
  • [10] A rare complication of bacillus Calmette-Guerin immunotherapy
    Vandermeersch, Denis
    Verroken, Alexia
    Mathys, Vanessa
    Pothen, Lucie
    [J]. ACTA CLINICA BELGICA, 2023, 78 : 29 - 30
12345